| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3904517 | Urology | 2010 | 6 Pages |
Abstract
The level of HNF-1B mRNA expression significantly decreases with tumor progression, and patients with high HNF-1B mRNA levels have a significantly better prognosis. HNF-1B might be a useful prognostic factor for metastatic RCC and also a potential therapeutic target in the future.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Alexander Buchner, Mirna Castro, Anja Hennig, Tanja Popp, Gerald Assmann, Christian G. Stief, Wolfgang Zimmermann,